Celltrion, 446,432 Shares Net Bought by Individuals in Last 5 Days... Stock Price at 293,500 KRW (-2.0%)

As of 1:31 PM on the 4th, Celltrion is trading at 293,500 KRW, down 2.0% from the previous day. The trading volume is 463,278 shares, which is 94.64% of the previous day's volume. Celltrion is known as a protein and biopharmaceutical manufacturing company.

On September 1st, Hana Financial Investment researchers Minjeong Seon and Seungwon Kang stated, "The fact that Celltrion's development and production items are biosimilars rather than new drugs raises clear concerns about maintaining continuous high growth and high margins. They are working on improving production yield through titer improvement, and through this, it is expected that even products released long ago, like Remsima, can continuously maintain high margins. The launch of the 1st biosimilar enables sustainable high growth." They set Celltrion's target price at 363,000 KRW.

Over the past five days, individual investors have net purchased 446,432 shares of Celltrion, while foreigners and institutions have net sold 439,585 shares and 18,992 shares, respectively.

※ Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.

This content was produced with the assistance of AI translation services.